Clinical Trial Update: Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oxaliplatin plus capecitabine versus observation after surgical resection of colorectal liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Arbeitsgruppe Lebermetastasen und Tumoren | Conditions: Colorectal Neoplasms, Liver Metastases | Phase 3 | Status: UNKNOWN